BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18978464)

  • 21. [Wiskott-Aldrich syndrome. Recent information apropos of 4 cases].
    Griscelli C; Phan-Huu-Trung ; Herzog C; Mozziconacci P
    Nouv Rev Fr Hematol; 1973; 13(4):554-68. PubMed ID: 4271105
    [No Abstract]   [Full Text] [Related]  

  • 22. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
    Carbonara A; Brusco A; Carbonara C
    Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms and consequences of somatic mosaicism in humans.
    Youssoufian H; Pyeritz RE
    Nat Rev Genet; 2002 Oct; 3(10):748-58. PubMed ID: 12360233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.
    Pasmooij AM; Pas HH; Bolling MC; Jonkman MF
    J Clin Invest; 2007 May; 117(5):1240-8. PubMed ID: 17476356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bibliography. Current world literature. Primary immune deficiency disease.
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):531-4. PubMed ID: 15051974
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulatory T cells in primary immunodeficiency diseases.
    Torgerson TR; Ochs HD
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):515-21. PubMed ID: 17989528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome.
    Gulácsy V; Freiberger T; Shcherbina A; Pac M; Chernyshova L; Avcin T; Kondratenko I; Kostyuchenko L; Prokofjeva T; Pasic S; Bernatowska E; Kutukculer N; Rascon J; Iagaru N; Mazza C; Tóth B; Erdos M; van der Burg M; Maródi L;
    Mol Immunol; 2011 Feb; 48(5):788-92. PubMed ID: 21185603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetic analysis of X-linked immunodeficiencies.
    Conley ME
    Year Immunol; 1993; 7():162-7. PubMed ID: 8372504
    [No Abstract]   [Full Text] [Related]  

  • 29. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
    van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revertant mosaicism in skin: natural gene therapy.
    Lai-Cheong JE; McGrath JA; Uitto J
    Trends Mol Med; 2011 Mar; 17(3):140-8. PubMed ID: 21195026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular characterization of Thai patients with Wiskott-Aldrich syndrome.
    Amarinthnukrowh P; Ittiporn S; Tongkobpetch S; Chatchatee P; Sosothikul D; Shotelersuk V; Suphapeetiporn K
    Scand J Immunol; 2013 Jan; 77(1):69-74. PubMed ID: 23033889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic recombination underlies frequent revertant mosaicism in loricrin keratoderma.
    Suzuki S; Nomura T; Miyauchi T; Takeda M; Fujita Y; Nishie W; Akiyama M; Ishida-Yamamoto A; Shimizu H
    Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30718378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
    Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
    Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen.
    Gostyński A; Pasmooij AM; Del Rio M; Diercks GF; Pas HH; Jonkman MF
    Exp Dermatol; 2014 Feb; 23(2):130-2. PubMed ID: 24330315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune deficiency and autoimmunity.
    Atkinson TP
    Curr Opin Rheumatol; 2012 Sep; 24(5):515-21. PubMed ID: 22820513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for primary adaptive immune deficiencies.
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
    Ariga T
    Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A possible bichromatid mutation in a male gamete giving rise to a female mosaic for two different mutations in the X-linked gene WAS.
    Dobbs AK; Yang T; Farmer DM; Howard V; Conley ME
    Clin Genet; 2007 Feb; 71(2):171-6. PubMed ID: 17250667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
    Lemahieu V; Gastier JM; Francke U
    Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunodeficiency disease genes on the X chromosome.
    Mensink EJ; Schuurman RK
    Dis Markers; 1987 Sep; 5(3):129-40. PubMed ID: 3332256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.